STRS Ohio’s Cardlytics CDLX Stock Holding History

STRS Ohio’s Portfolio CDLX Stock Details CDLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-390	Closed	-$13K	–	1965
2023 Q1	$13K	Hold	390	–	–	﹤0.01%	1890
2022 Q4	$22K	Hold	390	–	–	﹤0.01%	1875
2022 Q3	$36K	Hold	390	–	–	﹤0.01%	1869
2022 Q2	$87K	Buy	390 +70	+22%	+$23.4K	﹤0.01%	1787
2022 Q1	$175K	Hold	320	–	–	﹤0.01%	1734
2021 Q4	$211K	Hold	320	–	–	﹤0.01%	1718
2021 Q3	$268K	Buy	320 +130	+68%	+$132K	﹤0.01%	1693
2021 Q2	$241K	Buy	190 +20	+12%	+$22.6K	﹤0.01%	1760
2021 Q1	$186K	Sell	170 -20	-11%	-$26.4K	﹤0.01%	1808
2020 Q4	$271K	Sell	190 -170	-47%	-$181K	﹤0.01%	1679
2020 Q3	$254K	Hold	360	–	–	﹤0.01%	1603
2020 Q2	$251K	Buy	+360	New	+$208K	﹤0.01%	1587
2018 Q2	–	Sell	-150	Closed	-$21K	–	2124
2018 Q1	$21K	Buy	+150	New	+$25.4K	﹤0.01%	1817

Other funds holding CDLX

CIP

CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

KGAMU

KPS Global Asset Management (UK) London, United Kingdom $619M AUM 27.68% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

WPM

Worldly Partners Management Needham, Massachusetts $118M AUM 19.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

STRS Ohio's CDLX Position: Q2 2023 in Review

STRS Ohio sold out of Cardlytics (CDLX) in Q2 2023, closing a stake of 390 shares — an estimated $13K sold.

STRS Ohio first reported a position in CDLX in Q1 2018 and held it in 13 quarters. The position peaked at $271K in Q4 2020. 110 funds tracked by Wall St. Rank hold CDLX as of Q2 2023.

STRS Ohio reported no remaining Cardlytics position as of Q2 2023 after selling out during the quarter.
STRS Ohio sold 390 Cardlytics shares in Q2 2023, an estimated $13K.
STRS Ohio first reported a position in Cardlytics in Q1 2018 and held it in 13 quarters.
STRS Ohio's Cardlytics position peaked at $271K in Q4 2020.
110 funds tracked by Wall St. Rank held Cardlytics as of Q2 2023.

Based on STRS Ohio's 13F filing for Q2 2023, filed 31 Jul 2023.